Beranda › Kanker Endometrium › Texas › Austin
Uji klinis Kanker Endometrium di Austin, TX
15 studi untuk Kanker Endometrium mencari peserta di lokasi sekitar Austin (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Menerima pesertaFase 1/2
- New Experimental Therapeutics - NEXT Oncology, Austin
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1
- NEXT Austin, Austin
A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology, Austin
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
Menerima pesertaFase 3
- USOR - Texas Oncology, Austin
- USOR - Texas Oncology, Austin
- USOR - Texas Oncology- Austin North, Austin
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Menerima pesertaFase 3
- Research Site, Austin
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
Menerima pesertaFase 1
- NEXT Austin, Austin
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Austin, Austin
Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors
Menerima pesertaFase 1
- NEXT Oncology - Austin, Austin
Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
Menerima pesertaFase 1/2
- Texas Oncology - Central / South Texas, Austin
A Study of ART0380 for the Treatment of Advanced or Metastatic Solid Tumors
Menerima pesertaFase 1/2
- Texas Oncology - Central/South Texas, Austin
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
Menerima pesertaFase 3
- Research Site, Austin
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
Menerima pesertaFase 1
- NEXT Texas LLC - Austin, Austin
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Elligo Health Research, Inc., Austin
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Menerima pesertaFase 1
- Dren Investigational Site, Austin
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Menerima pesertaFase 2/3
- Texas Oncology-Austin Central, Austin
Uji klinis Kanker Endometrium di kota lain
- Houston, TX68 studi
- New York City, NY52 studi
- Boston, MA50 studi
- Arlington, VA39 studi
- Nashville, TN38 studi
- Los Angeles, CA34 studi
- St. Louis, MO29 studi
- Philadelphia, PA28 studi
- San Antonio, TX27 studi
- Queens, NY25 studi
- Columbus, OH25 studi
- Chicago, IL25 studi
Studi lain di Austin
- Kanker Paru Non-Sel Kecil30 studi
- Kanker (semua jenis)20 studi
- Obesitas20 studi
- Kanker Metastatik19 studi
- Kanker Kolorektal19 studi
- Gagal Jantung18 studi
- Kanker Payudara18 studi
- Kelebihan Berat Badan18 studi
- Kanker Ovarium17 studi
- Kanker Prostat15 studi
- Depresi14 studi
- Kanker Payudara Triple-Negatif13 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.